Ideagen PLC Director/PDMR Shareholding (8913W)
13 Diciembre 2019 - 10:38AM
UK Regulatory
TIDMIDEA
RNS Number : 8913W
Ideagen PLC
13 December 2019
Ideagen PLC
("Ideagen," "the Company" or the "Group")
Director Dealing
Ideagen PLC (AIM: IDEA), a leading supplier of Information
Management Software to highly regulated industries, announces that
Alan Carroll, a non-executive director, has purchased 93 ordinary
shares of 1p each in the Company ('Ordinary Shares') at a price of
169.9 pence each (the 'Purchase') as a result of the automatic
reinvestment of the Company's recent dividend by his nominated
broker.
In addition, Mr Carroll sold 11,566 Ordinary Shares at a price
of 168.0 pence each and purchased 11,566 shares at a price of
168.26 pence into his ISA.
Following the Purchase, Mr Carroll's beneficial interest has
increased to 204,264 shares representing approximately 0.1% of the
Company's issued ordinary share capital.
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) No 596/2014.
Enquiries:
Ideagen plc 01629 699100
David Hornsby, Executive Chairman
Ben Dorks, Chief Executive
Graeme Spenceley, Finance Director
finnCap Limited 020 7220 0500
Henrik Persson/James Thompson
(Nomad)
Alice Lane (ECM)
Canaccord Genuity 020 7523 8000
Simon Bridges
Richard Andrews
About Ideagen plc
Ideagen is a UK-headquartered, global technology company quoted
on the London Stock Exchange AIM market (Ticker: IDEA.L).
The Group provides software and services to organisations
operating within highly regulated industries such as aviation,
banking and finance and life science, with its main operational
premises spread throughout the UK, EU, US, Middle East and SE
Asia.
With an excellent portfolio of software products including
Q-Pulse, Coruson, Pentana Audit and PleaseReview, Ideagen helps its
clients reduce costs, improve operational efficiency, strengthen
compliance and oversight and anticipate and manage every detail of
risk.
Currently, more than 4,700 organisations use Ideagen's products
including seven of the top 10 UK accounting firms, all of the top
aerospace and defence companies and 75% of the world's leading
pharmaceutical firms.
Ideagen's diverse and varied customer base includes many
well-known, global brands such as British Airways, Aggreko, BAE,
Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank,
Meggitt, Heineken, Johnson Matthey, Haeco Group and European
Central Bank. As well as this, Ideagen counts 180 hospitals across
the UK and US amongst its client base.
For further information please visit www.ideagen.com.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name Alan Carroll
---------------------------------------------- -----------------------------------------------
2. Reason for the Notification
-----------------------------------------------------------------------------------------------
a) Position/status Non-executive Director
---------------------------------------------- -----------------------------------------------
b) Initial notification/Amendment Initial notification
---------------------------------------------- -----------------------------------------------
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
-----------------------------------------------------------------------------------------------
a) Name Ideagen PLC
---------------------------------------------- -----------------------------------------------
b) LEI 213800KS1MLITOVNYC85
---------------------------------------------- -----------------------------------------------
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
-----------------------------------------------------------------------------------------------
a) Description of the Financial Ordinary Shares of 1p each
instrument, type of instrument
---------------------------------------------- -----------------------------------------------
Identification code GB00B0CM0C50
---------------------------------------------- -----------------------------------------------
b) Nature of the transaction Purchase of shares & Sale and
buyback of shares to effect
a transfer of shares into ISA
---------------------------------------------- -----------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
169.9p 93
168.0p 11,566
168.26p 11,566
----------
---------------------------------------------- -----------------------------------------------
d) Aggregated information: Automatic reinvestment of recent
-- Aggregated volume dividend into 93 ordinary shares
-- Price at a price of 169.9p.
Sale of 11,566 ordinary shares
at 168p. Buy back, into ISA,
of 11,566 ordinary shares at
168.26p
---------------------------------------------- -----------------------------------------------
e) Date of the transaction 12 December 2019
---------------------------------------------- -----------------------------------------------
f) Place of the transaction London Stock Exchange (XLON)
---------------------------------------------- -----------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHFMMMZVFVGLZM
(END) Dow Jones Newswires
December 13, 2019 11:38 ET (16:38 GMT)
Ideagen (LSE:IDEA)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Ideagen (LSE:IDEA)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024